InsidersTradesSigma
Track the 에이프로젠바이오로직스 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 에이프로젠바이오로직스 has logged 13 insider filings. Market capitalisation: €28.5bn. The latest transaction was disclosed on 8 May 2026 (Sale). Among the most active insiders: 에이프로젠. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
13 of 13 declarations
Aprogen Biologics是一家专注于生物制药产品开发的公司。它在XKRX市场上市。